← back to search

Guiling Li

Shanghai Medical College of Fudan University · CN
🔎 Find collaborators in Molecular Biology · Cancer Research →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Cancer Research
Research interest
Research focused on Oncology and Plasmid, with related work in Klebsiella pneumoniae, Ovarian cancer, Disease. Notable publications include 'Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study', 'ApoE/NOS3 Knockout Mice as a Novel Cardiovascular Disease Model of Hypertension and Atherosclerosis', and 'Clinical update related to the first-in-human trial of SYS6002 (CRB-701), a next-generation nectin-4 targeting antibody drug conjugate'.
h-index
citations
76
works
11
NIH funding
primary concept
email

Recent publications

Dictamnine alleviates DSS-induced colitis mice by inhibiting ferroptosis of enterocytes via activating Nrf2-Gpx4 signaling pathway
European Journal of Pharmacology 2025cited by 5position: middledoi
LBA38 Phase III study of camrelizumab plus famitinib versus platinum-based chemotherapy as first-line therapy for recurrent or metastatic cervical cancer
Annals of Oncology 2025cited by 1position: middledoi
Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors
Experimental Hematology and Oncology 2025cited by 1position: middledoi
Enlonstobart in patients with PD-L1 positive recurrent/metastatic cervical cancer: Updated survival results of the phase II study.
Journal of Clinical Oncology 2025cited by 0position: middledoi
Development and Clinical Trial of M701, an Anti-EpCAM × Anti-CD3 Bispecific Antibody: A Targeted Intraperitoneal Therapy for Malignant Ascites Stemming from Advanced Solid Tumors
Research Square 2025cited by 0position: middledoi
Clinical update related to the first-in-human trial of SYS6002 (CRB-701), a next-generation nectin-4 targeting antibody drug conjugate.
Journal of Clinical Oncology 2024cited by 10position: middledoi
Efficacy and safety of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with solid tumors: Clinical data from advanced cervical cancer and platinum-resistant recurrent ovarian cancer cohorts.
Journal of Clinical Oncology 2024cited by 4position: middledoi
EP323/#463  Efficacy and safety of mirvetuximab soravtansine in Chinese patients with platinum-resistant ovarian cancer with high folate receptor alpha expression: results from IMGN853–301 (Soraya China) study
International Journal of Gynecological Cancer 2023cited by 5position: middledoi
Study on the Role of ampG in the Regulation of Plasmid-Mediated ampC -Induced Expression in Klebsiella pneumoniae
Infection and Drug Resistance 2023cited by 1position: firstdoi
Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study
Protein & Cell 2022cited by 28position: middledoi
ApoE/NOS3 Knockout Mice as a Novel Cardiovascular Disease Model of Hypertension and Atherosclerosis
Genes 2022cited by 16position: middledoi
DHA-1 plasmid-mediated AmpC β-lactamase expression and regulation of Klebsiella pnuemoniae isolates
Molecular Medicine Reports 2014cited by 8position: middledoi
Identification of Genotypes of Plasmid-Encoded AmpC β-Lactamases From Clinical Isolates and Characterization of Mutations in Their Promoter and Attenuator Regions
Gene Expression 2013cited by 6position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Ying Luan · Harbin Medical University3 papers (2013–2023)Ying Cheng · Wenzhou Medical University2 papers (2024–2025) · 2 papers (2013–2014)HE-GUANG ZHANG · Harbin Medical University2 papers (2013–2014)Lingying Wu · State Key Laboratory of Electronic Thin Films and Integrated Devices2 papers (2024–2025)Li-Bo Duo · Harbin Medical University2 papers (2014–2023)Rutie Yin · Sichuan University2 papers (2023–2025)Deyu Li · Massachusetts Institute of Technology1 papers (2025–2025)Lihong Chen · Guangzhou University of Chinese Medicine1 papers (2023–2023)Lin An · Guangzhou University of Chinese Medicine1 papers (2024–2024)Yongmei Yin · Harbin Medical University1 papers (2024–2024)Huifeng Zhang · Tang Du Hospital1 papers (2023–2023)Shaogang Wang · Tongji Hospital1 papers (2025–2025)Li Sun · Jiangsu University1 papers (2025–2025)Daren Lin · Jiangmen Central Hospital1 papers (2025–2025)Qi Sun · Harbin Medical University1 papers (2023–2023) · 1 papers (2024–2024)Xin Yuan · Guangzhou University of Chinese Medicine1 papers (2025–2025)Yang Gao · Fudan University1 papers (2025–2025)Fei He · Harbin Medical University1 papers (2014–2014)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Cancer Research →